Additional file 1 of Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis

Supplementary Material 1: Table S1. Significant results of eQTL MR analysis. Table S2. Genetic information of SNPs associated with druggable genes. Table S3. Results of MR-Egger and MR-PRESSO analysis for pleiotropy test. Table S4. Results of Q and I2 analysis for heterogeneity test. Table S5. Results of F statistics and Steiger filtering analysis. Table S6. Results of colocalization analysis. Table S7. Results of pQTL MR analysis. Table S8. Characteristics of MG patients and healthy controls. Table S9. Clinical trial information of promising drug targets. Table S10. 821 phenotypes included for Phenome-wide MR (Phe-MR) analysis. Table S11. Results of Phe-MR analysis.